Search Results

There are 7504 results for: content related to: Oseltamivir phosphate–amberlite TM IRP 64 ionic complex for taste masking: Preparation and chemometric evaluation

  1. You have free access to this content
    Neuraminidase inhibitors for preventing and treating influenza in adults and children

    Intervention Review

    The Cochrane Library

    Tom Jefferson, Mark A Jones, Peter Doshi, Chris B Del Mar, Rokuro Hama, Matthew J Thompson, Elizabeth A Spencer, Igho J Onakpoya, Kamal R Mahtani, David Nunan, Jeremy Howick and Carl J Heneghan

    Published Online : 10 APR 2014, DOI: 10.1002/14651858.CD008965.pub4

  2. You have free access to this content
    Cochrane Review: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 7, Issue 5, September 2012, Pages: 1719–1790, Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera and Anthony Harnden

    Version of Record online : 6 SEP 2012, DOI: 10.1002/ebch.1871

  3. You have free access to this content
    Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

    Intervention Review

    The Cochrane Library

    Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera and Anthony Harnden

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD002744.pub4

  4. Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

    The Journal of Clinical Pharmacology

    Volume 48, Issue 8, August 2008, Pages: 935–947, Dr Craig R. Rayner, Dr Pascal Chanu, Dr Ronald Gieschke, Dr Lauren M. Boak and Dr E. Niclas Jonsson

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008320317

  5. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Version of Record online : 29 MAR 2011, DOI: 10.1002/pds.2136

  6. You have free access to this content
    Oseltamivir Blocks Human Neuronal Nicotinic Acetylcholine Receptor-Mediated Currents

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 2, February 2015, Pages: 87–95, Katsuhiko Muraki, Noriyuki Hatano, Hiroka Suzuki, Yukiko Muraki, Yui Iwajima, Yasuhiro Maeda and Hideki Ono

    Version of Record online : 31 JUL 2014, DOI: 10.1111/bcpt.12290

  7. Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 2007, Pages: 689–696, Jerome J. Schentag, George Hill, Tom Chu and Craig R. Rayner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007299761

  8. Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children

    Pediatrics International

    Volume 57, Issue 3, June 2015, Pages: 393–400, Jacqueline K Lim, Paul E Kilgore, Allison E Aiello, Betsy Foxman, G William Letson, Gi-Young Jang, Eunhee Chung, Young-Hwan Song and Yun-Kyung Kim

    Version of Record online : 22 JAN 2015, DOI: 10.1111/ped.12526

  9. Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 1, July 2012, Pages: 68–71, E K Tarkiainen, J T Backman, M Neuvonen, P J Neuvonen, M Schwab and M Niemi

    Version of Record online : 16 MAY 2012, DOI: 10.1038/clpt.2012.13

  10. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009–2011

    Journal of Medical Virology

    Volume 85, Issue 3, March 2013, Pages: 379–387, Ji-Rong Yang, Yuan-Pin Huang, Feng-Yee Chang, Li-Ching Hsu, Hsiang-Yi Huang, Yi-Tsan Pan, Yu-Cheng Lin, Ho-Sheng Wu and Ming-Tsan Liu

    Version of Record online : 21 DEC 2012, DOI: 10.1002/jmv.23482

  11. You have free access to this content
    Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 9, September 2011, Pages: 3854–3861, Kaori Morimoto, Kozue Kishimura, Takaaki Nagami, Nao Kodama, Yoichiro Ogama, Midori Yokoyama, Shinya Toda, Takeshi Chiyoda, Rieko Shimada, Akihiro Inano, Takashi Kano, Ikumi Tamai and Takuo Ogihara

    Version of Record online : 23 MAY 2011, DOI: 10.1002/jps.22627

  12. Absence of Pharmacokinetic Interaction Between Intravenous Peramivir and Oral Oseltamivir or Rimantadine in Humans

    The Journal of Clinical Pharmacology

    Volume 52, Issue 9, September 2012, Pages: 1410–1419, George Atiee, Kenneth Lasseter, Sharon Baughman, Amy McCullough, Phil Collis, Alan Hollister and Jaime Hernandez

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011414574

  13. Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study

    The Journal of Clinical Pharmacology

    Volume 52, Issue 8, August 2012, Pages: 1255–1264, Georgina Cirrincione-Dall, Barbara J. Brennan, Rosa M. Ballester-Sanchis, Mercidita T. Navarro and Brian E. Davies

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011412960

  14. You have full text access to this Open Access content
    Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

    Influenza and Other Respiratory Viruses

    Volume 7, Issue s1, January 2013, Pages: 25–36, Jennifer L. McKimm-Breschkin

    Version of Record online : 28 DEC 2012, DOI: 10.1111/irv.12047

  15. Pharmacokinetic Properties ofAnti-Influenza Neuraminidase Inhibitors

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 119–139, Kalayanee Chairat, Joel Tarning, Nicholas J. White and Niklas Lindegardh

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270012440280

  16. You have free access to this content
    Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients

    British Journal of Clinical Pharmacology

    Volume 70, Issue 6, December 2010, Pages: 834–843, Brian E. Davies, Pau Aceves Baldó, Sian Lennon-Chrimes and Mike Brewster

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1365-2125.2010.03780.x

  17. You have full text access to this OnlineOpen article
    Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers

    British Journal of Clinical Pharmacology

    Volume 81, Issue 6, June 2016, Pages: 1103–1112, Kalayanee Chairat, Podjanee Jittamala, Warunee Hanpithakpong, Nicholas P. J. Day, Nicholas J. White, Sasithon Pukrittayakamee and Joel Tarning

    Version of Record online : 4 MAR 2016, DOI: 10.1111/bcp.12892

  18. Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal Membrane Oxygenation

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1061–1069, Rachel F. Eyler, Michael Heung, Melissa Pleva, Kevin M. Sowinski, Pauline K. Park, Lena M. Napolitano and Bruce A. Mueller

    Version of Record online : 3 DEC 2012, DOI: 10.1002/phar.1151

  19. Cochrane review: Neuraminidase inhibitors for preventing and treating influenza in children

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 3, Issue 2, June 2008, Pages: 540–582, NJ Matheson, AR Harnden, R Perera, A Sheikh and M Symmonds-Abrahams

    Version of Record online : 3 JUN 2008, DOI: 10.1002/ebch.243

  20. You have full text access to this OnlineOpen article
    The mechanisms of sudden-onset type adverse reactions to oseltamivir

    Acta Neurologica Scandinavica

    Volume 135, Issue 2, February 2017, Pages: 148–160, R. Hama and C. L. Bennett

    Version of Record online : 30 JUN 2016, DOI: 10.1111/ane.12629